Suppr超能文献

比卡鲁胺在异性恋和同性恋前列腺癌患者中的初步研究:雄激素在男性同性恋唤起中的可能作用。

Preliminary study with bicalutamide in heterosexual and homosexual patients with prostate cancer: a possible implication of androgens in male homosexual arousal.

机构信息

St Pantelimon Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

出版信息

BJU Int. 2011 Jul;108(1):110-5. doi: 10.1111/j.1464-410X.2010.09764.x. Epub 2010 Oct 18.

Abstract

OBJECTIVE

• Not only has a precise characterization of libido and sexual arousal in men as a central neural process been lacking, but the interactive role of gonadal hormones and sexual orientation in such processes has never been investigated. We investigate the relationships among sexual hormones, sexual arousal, and sexual orientation in men by comparing the self-reported sexual response of heterosexual and homosexual men with locally advanced prostate neoplasm, receiving the non-steroidal anti-androgen bicalutamide as monotherapy.

PATIENTS AND METHODS

• 29 Romanian men participated in this study: 17 heterosexual and 12 homosexual. Patients were undergoing treatment for prostate cancer consisting of a standard daily dose of 50 mg bicalutamide, a fast acting non-steroidal anti-androgen with action comparable to other anti-androgen drugs but with reportedly fewer sexual side effects. • Patients retrospectively provided information regarding their sexual functioning measured by the IIEF prior to commencing bicalutamide treatment. • Then, about five weeks later, patients were asked to prospectively provide information regarding their current sexual functioning while undergoing bicalutamide treatment.

RESULTS

• Overall IIEF scores as well as the Erectile Function, Orgasmic Function, Sexual Desire, and Overall Satisfaction subscales showed group, treatment, and group by treatment effects. • The Intercourse Satisfaction subscale showed group and group by treatment effects. • On most subscales, homosexual men showed lower functioning than heterosexual men, primarily in response to treatment with bicalutamide.

CONCLUSIONS

• Treatment with an anti-androgen in a clinical population of men undergoing therapy for prostate cancer affected homosexual men more than heterosexual men, although not all heterosexual men were unaffected. • These results are discussed in the context of dual sexual natures, a concept recently developed in the sexual literature. • Furthermore, these findings reiterate the importance of incorporating such variables as sexual orientation into studies investigating medical treatments on sexual response.

摘要

目的

  • 不仅缺乏对男性性欲和性唤起作为中央神经过程的精确描述,而且从未研究过性腺激素和性取向在这些过程中的相互作用。

  • 我们通过比较接受非甾体类抗雄激素比卡鲁胺单药治疗的局部晚期前列腺癌的异性恋和同性恋男性的自我报告性反应,来研究男性的性激素、性唤起和性取向之间的关系。

方法

  • 29 名罗马尼亚男性参与了这项研究:17 名异性恋男性和 12 名同性恋男性。

  • 患者正在接受前列腺癌治疗,包括标准的每日 50mg 比卡鲁胺剂量,这是一种快速作用的非甾体类抗雄激素,其作用与其他抗雄激素药物相当,但据报道副作用较少。

  • 患者在开始比卡鲁胺治疗前回顾性地提供了他们的性功能信息,使用国际勃起功能指数(IIEF)进行测量。

  • 然后,大约五周后,患者在接受比卡鲁胺治疗时前瞻性地提供了他们当前的性功能信息。

结果

  • 总体 IIEF 评分以及勃起功能、射精功能、性欲和总体满意度子量表均显示出组间、治疗间和组间治疗效果。

  • 性交满意度子量表显示出组间和组间治疗效果。

  • 在大多数子量表上,同性恋男性的功能比异性恋男性低,主要是由于接受比卡鲁胺治疗的影响。

结论

  • 在接受前列腺癌治疗的男性临床人群中,使用抗雄激素治疗对同性恋男性的影响大于异性恋男性,尽管并非所有异性恋男性都不受影响。

  • 这些结果在性文献中最近提出的双重性本质概念的背景下进行了讨论。

  • 此外,这些发现强调了在研究医学治疗对性反应的影响时,将性取向等变量纳入研究的重要性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验